HomeScienceDamaged DNA could warn of Parkinson's before its symptoms appear

Damaged DNA could warn of Parkinson's before its symptoms appear

Possible biomarker could predict the onset of a disorder long before symptoms of cognitive and physical deterioration appear

Barcelona scientists believe they have identified a possible biomarker that can predict the appearance of a disorder that gives rise to diseases such as Parkinson's long before symptoms of cognitive and physical deterioration appear.

These specific markers circulating in the blood and cerebrospinal fluid (CSF) precede most of the physical and cognitive symptoms of Parkinson's and dementia, potentially giving individuals more time to prepare for or one day even prevent these conditions. .

Unfortunately, most of the outward symptoms of Parkinson's do not manifest until the vast majority of dopaminergic neurons are already damaged, and the telltale protein clumps called Lewy bodies are of no use to living patients, since they can only be verified at the autopsy.

In human cells, including neurons, not all DNA is enclosed in the nucleus. The energy-generating part of the cell, the mitochondria, has its own genetic material, called mitochondrial DNA (mtDNA), which comes only from the mother.

The fact that mtDNA is so close to the sites where free radicals are produced is thought to be one of the reasons why it is relatively vulnerable to dysfunction over time, compared to DNA located further away. except in the core envelope.

There is increasing evidence that mitochondrial dysfunction is closely related to the development of Parkinson's and a form of dementia associated with Lewy bodies.

But it remains unclear whether damaged mtDNA molecules predict the disease, appearing in the first few days, or are a byproduct of the disease, appearing later. The new findings from Spain give more weight to the first version.

The study focused on 17 patients with idiopathic REM sleep behavior disorder (RSBD), which causes unpleasant dreams and vigorous physical behaviors during REM sleep.

This disorder is commonly experienced by those who are later diagnosed with Parkinson's or dementia with Lewy bodies.

Ultimately, the team of researchers, led by Margalida Puigròs at the Barcelona Biomedical Research Institute, found a significantly higher number of damaged mtDNA molecules in the CSF of patients with TCSR, and of those who later also received a diagnosis of Parkinson's disease or dementia with Lewy bodies, compared to unaffected controls.

People with SRBD who later developed Lewy body disorder also had more copies of damaged and intact mtDNA in their blood serum, compared to those who did not develop PD or Lewy body dementia, or who never had IRBD.

In a second subgroup analysis, 11 patients with TCSR who had not yet been diagnosed with Parkinson's were followed over time. Those who subsequently developed Parkinson's or Lewy body dementia showed a similar number of damaged mtDNA molecules compared to those who did not develop Lewy body disorder.

This suggests that high levels of damaged mtDNA "are already present in RSBD, long before it develops into Lewy body dementia," the researchers write in their article. Meanwhile, people who had higher numbers of damaged mtDNA molecules in their CSF samples tended to receive an earlier diagnosis of Parkinson's or Lewy body dementia.

This correlation suggests that mtDNA dysfunction may be "a critical molecular mechanism in the early stages of neurodegeneration." The emerging link between the brain's energy metabolism and Parkinson's is providing some of the most promising leads yet, Sputnik reported in a press release, according to a study by eBioMedicine.

Loading…
SOURCESputnik

Leave a response

Please enter your comment!
Please enter your name here